Another experiment performed on human subjects used positron emission tomography to compare the effects of exogenous oxytocin administration as a modulator on serotonergic neurotransmission in patients with autism spectrum disorder versus control patients. The gene discussed is OXT; the disease is autism spectrum disorder.